Global AI Drug Development Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global AI Drug Development market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global AI Drug Development market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global AI Drug Development market size and forecasts, in consumption value ($ Million), 2018-2029
Global AI Drug Development market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global AI Drug Development market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global AI Drug Development market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Drug Development
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Drug Development market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited and AiCure, LLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
AI Drug Development market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe AI Drug Development product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Development, with revenue, gross margin and global market share of AI Drug Development from 2018 to 2023.
Chapter 3, the AI Drug Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI Drug Development market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Development.
Chapter 13, to describe AI Drug Development research findings and conclusion.
This report is a detailed and comprehensive analysis for global AI Drug Development market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global AI Drug Development market size and forecasts, in consumption value ($ Million), 2018-2029
Global AI Drug Development market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global AI Drug Development market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global AI Drug Development market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for AI Drug Development
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global AI Drug Development market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Insilico Medicine, Cyclica, XtalPi Inc., Exscientia Limited and AiCure, LLC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
AI Drug Development market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Drug Design
- Drug Synthesis
- Other
- Tumor
- Nervous System
- Other
- Insilico Medicine
- Cyclica
- XtalPi Inc.
- Exscientia Limited
- AiCure, LLC
- Atomwise
- Biovista Inc.
- Breg?Inc.
- Numerate
- Cloud Pharmaceuticals
- IBM
- NuMedii
- BenevolentAI
- Lam Therapeutics
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe AI Drug Development product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of AI Drug Development, with revenue, gross margin and global market share of AI Drug Development from 2018 to 2023.
Chapter 3, the AI Drug Development competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and AI Drug Development market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of AI Drug Development.
Chapter 13, to describe AI Drug Development research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of AI Drug Development
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Drug Development by Type
1.3.1 Overview: Global AI Drug Development Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global AI Drug Development Consumption Value Market Share by Type in 2022
1.3.3 Drug Design
1.3.4 Drug Synthesis
1.3.5 Other
1.4 Global AI Drug Development Market by Application
1.4.1 Overview: Global AI Drug Development Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Nervous System
1.4.4 Other
1.5 Global AI Drug Development Market Size & Forecast
1.6 Global AI Drug Development Market Size and Forecast by Region
1.6.1 Global AI Drug Development Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global AI Drug Development Market Size by Region, (2018-2029)
1.6.3 North America AI Drug Development Market Size and Prospect (2018-2029)
1.6.4 Europe AI Drug Development Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific AI Drug Development Market Size and Prospect (2018-2029)
1.6.6 South America AI Drug Development Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa AI Drug Development Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Insilico Medicine
2.1.1 Insilico Medicine Details
2.1.2 Insilico Medicine Major Business
2.1.3 Insilico Medicine AI Drug Development Product and Solutions
2.1.4 Insilico Medicine AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Insilico Medicine Recent Developments and Future Plans
2.2 Cyclica
2.2.1 Cyclica Details
2.2.2 Cyclica Major Business
2.2.3 Cyclica AI Drug Development Product and Solutions
2.2.4 Cyclica AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cyclica Recent Developments and Future Plans
2.3 XtalPi Inc.
2.3.1 XtalPi Inc. Details
2.3.2 XtalPi Inc. Major Business
2.3.3 XtalPi Inc. AI Drug Development Product and Solutions
2.3.4 XtalPi Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 XtalPi Inc. Recent Developments and Future Plans
2.4 Exscientia Limited
2.4.1 Exscientia Limited Details
2.4.2 Exscientia Limited Major Business
2.4.3 Exscientia Limited AI Drug Development Product and Solutions
2.4.4 Exscientia Limited AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Exscientia Limited Recent Developments and Future Plans
2.5 AiCure, LLC
2.5.1 AiCure, LLC Details
2.5.2 AiCure, LLC Major Business
2.5.3 AiCure, LLC AI Drug Development Product and Solutions
2.5.4 AiCure, LLC AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AiCure, LLC Recent Developments and Future Plans
2.6 Atomwise
2.6.1 Atomwise Details
2.6.2 Atomwise Major Business
2.6.3 Atomwise AI Drug Development Product and Solutions
2.6.4 Atomwise AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Atomwise Recent Developments and Future Plans
2.7 Biovista Inc.
2.7.1 Biovista Inc. Details
2.7.2 Biovista Inc. Major Business
2.7.3 Biovista Inc. AI Drug Development Product and Solutions
2.7.4 Biovista Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biovista Inc. Recent Developments and Future Plans
2.8 Breg?Inc.
2.8.1 Breg?Inc. Details
2.8.2 Breg?Inc. Major Business
2.8.3 Breg?Inc. AI Drug Development Product and Solutions
2.8.4 Breg?Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Breg?Inc. Recent Developments and Future Plans
2.9 Numerate
2.9.1 Numerate Details
2.9.2 Numerate Major Business
2.9.3 Numerate AI Drug Development Product and Solutions
2.9.4 Numerate AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Numerate Recent Developments and Future Plans
2.10 Cloud Pharmaceuticals
2.10.1 Cloud Pharmaceuticals Details
2.10.2 Cloud Pharmaceuticals Major Business
2.10.3 Cloud Pharmaceuticals AI Drug Development Product and Solutions
2.10.4 Cloud Pharmaceuticals AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.11 IBM
2.11.1 IBM Details
2.11.2 IBM Major Business
2.11.3 IBM AI Drug Development Product and Solutions
2.11.4 IBM AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 IBM Recent Developments and Future Plans
2.12 NuMedii
2.12.1 NuMedii Details
2.12.2 NuMedii Major Business
2.12.3 NuMedii AI Drug Development Product and Solutions
2.12.4 NuMedii AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 NuMedii Recent Developments and Future Plans
2.13 BenevolentAI
2.13.1 BenevolentAI Details
2.13.2 BenevolentAI Major Business
2.13.3 BenevolentAI AI Drug Development Product and Solutions
2.13.4 BenevolentAI AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 BenevolentAI Recent Developments and Future Plans
2.14 Lam Therapeutics
2.14.1 Lam Therapeutics Details
2.14.2 Lam Therapeutics Major Business
2.14.3 Lam Therapeutics AI Drug Development Product and Solutions
2.14.4 Lam Therapeutics AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Lam Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Drug Development Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of AI Drug Development by Company Revenue
3.2.2 Top 3 AI Drug Development Players Market Share in 2022
3.2.3 Top 6 AI Drug Development Players Market Share in 2022
3.3 AI Drug Development Market: Overall Company Footprint Analysis
3.3.1 AI Drug Development Market: Region Footprint
3.3.2 AI Drug Development Market: Company Product Type Footprint
3.3.3 AI Drug Development Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Drug Development Consumption Value and Market Share by Type (2018-2023)
4.2 Global AI Drug Development Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Drug Development Consumption Value Market Share by Application (2018-2023)
5.2 Global AI Drug Development Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America AI Drug Development Consumption Value by Type (2018-2029)
6.2 North America AI Drug Development Consumption Value by Application (2018-2029)
6.3 North America AI Drug Development Market Size by Country
6.3.1 North America AI Drug Development Consumption Value by Country (2018-2029)
6.3.2 United States AI Drug Development Market Size and Forecast (2018-2029)
6.3.3 Canada AI Drug Development Market Size and Forecast (2018-2029)
6.3.4 Mexico AI Drug Development Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe AI Drug Development Consumption Value by Type (2018-2029)
7.2 Europe AI Drug Development Consumption Value by Application (2018-2029)
7.3 Europe AI Drug Development Market Size by Country
7.3.1 Europe AI Drug Development Consumption Value by Country (2018-2029)
7.3.2 Germany AI Drug Development Market Size and Forecast (2018-2029)
7.3.3 France AI Drug Development Market Size and Forecast (2018-2029)
7.3.4 United Kingdom AI Drug Development Market Size and Forecast (2018-2029)
7.3.5 Russia AI Drug Development Market Size and Forecast (2018-2029)
7.3.6 Italy AI Drug Development Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Drug Development Consumption Value by Type (2018-2029)
8.2 Asia-Pacific AI Drug Development Consumption Value by Application (2018-2029)
8.3 Asia-Pacific AI Drug Development Market Size by Region
8.3.1 Asia-Pacific AI Drug Development Consumption Value by Region (2018-2029)
8.3.2 China AI Drug Development Market Size and Forecast (2018-2029)
8.3.3 Japan AI Drug Development Market Size and Forecast (2018-2029)
8.3.4 South Korea AI Drug Development Market Size and Forecast (2018-2029)
8.3.5 India AI Drug Development Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia AI Drug Development Market Size and Forecast (2018-2029)
8.3.7 Australia AI Drug Development Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America AI Drug Development Consumption Value by Type (2018-2029)
9.2 South America AI Drug Development Consumption Value by Application (2018-2029)
9.3 South America AI Drug Development Market Size by Country
9.3.1 South America AI Drug Development Consumption Value by Country (2018-2029)
9.3.2 Brazil AI Drug Development Market Size and Forecast (2018-2029)
9.3.3 Argentina AI Drug Development Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Drug Development Consumption Value by Type (2018-2029)
10.2 Middle East & Africa AI Drug Development Consumption Value by Application (2018-2029)
10.3 Middle East & Africa AI Drug Development Market Size by Country
10.3.1 Middle East & Africa AI Drug Development Consumption Value by Country (2018-2029)
10.3.2 Turkey AI Drug Development Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia AI Drug Development Market Size and Forecast (2018-2029)
10.3.4 UAE AI Drug Development Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 AI Drug Development Market Drivers
11.2 AI Drug Development Market Restraints
11.3 AI Drug Development Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Drug Development Industry Chain
12.2 AI Drug Development Upstream Analysis
12.3 AI Drug Development Midstream Analysis
12.4 AI Drug Development Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of AI Drug Development
1.2 Market Estimation Caveats and Base Year
1.3 Classification of AI Drug Development by Type
1.3.1 Overview: Global AI Drug Development Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global AI Drug Development Consumption Value Market Share by Type in 2022
1.3.3 Drug Design
1.3.4 Drug Synthesis
1.3.5 Other
1.4 Global AI Drug Development Market by Application
1.4.1 Overview: Global AI Drug Development Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Tumor
1.4.3 Nervous System
1.4.4 Other
1.5 Global AI Drug Development Market Size & Forecast
1.6 Global AI Drug Development Market Size and Forecast by Region
1.6.1 Global AI Drug Development Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global AI Drug Development Market Size by Region, (2018-2029)
1.6.3 North America AI Drug Development Market Size and Prospect (2018-2029)
1.6.4 Europe AI Drug Development Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific AI Drug Development Market Size and Prospect (2018-2029)
1.6.6 South America AI Drug Development Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa AI Drug Development Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Insilico Medicine
2.1.1 Insilico Medicine Details
2.1.2 Insilico Medicine Major Business
2.1.3 Insilico Medicine AI Drug Development Product and Solutions
2.1.4 Insilico Medicine AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Insilico Medicine Recent Developments and Future Plans
2.2 Cyclica
2.2.1 Cyclica Details
2.2.2 Cyclica Major Business
2.2.3 Cyclica AI Drug Development Product and Solutions
2.2.4 Cyclica AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Cyclica Recent Developments and Future Plans
2.3 XtalPi Inc.
2.3.1 XtalPi Inc. Details
2.3.2 XtalPi Inc. Major Business
2.3.3 XtalPi Inc. AI Drug Development Product and Solutions
2.3.4 XtalPi Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 XtalPi Inc. Recent Developments and Future Plans
2.4 Exscientia Limited
2.4.1 Exscientia Limited Details
2.4.2 Exscientia Limited Major Business
2.4.3 Exscientia Limited AI Drug Development Product and Solutions
2.4.4 Exscientia Limited AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Exscientia Limited Recent Developments and Future Plans
2.5 AiCure, LLC
2.5.1 AiCure, LLC Details
2.5.2 AiCure, LLC Major Business
2.5.3 AiCure, LLC AI Drug Development Product and Solutions
2.5.4 AiCure, LLC AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 AiCure, LLC Recent Developments and Future Plans
2.6 Atomwise
2.6.1 Atomwise Details
2.6.2 Atomwise Major Business
2.6.3 Atomwise AI Drug Development Product and Solutions
2.6.4 Atomwise AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Atomwise Recent Developments and Future Plans
2.7 Biovista Inc.
2.7.1 Biovista Inc. Details
2.7.2 Biovista Inc. Major Business
2.7.3 Biovista Inc. AI Drug Development Product and Solutions
2.7.4 Biovista Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biovista Inc. Recent Developments and Future Plans
2.8 Breg?Inc.
2.8.1 Breg?Inc. Details
2.8.2 Breg?Inc. Major Business
2.8.3 Breg?Inc. AI Drug Development Product and Solutions
2.8.4 Breg?Inc. AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Breg?Inc. Recent Developments and Future Plans
2.9 Numerate
2.9.1 Numerate Details
2.9.2 Numerate Major Business
2.9.3 Numerate AI Drug Development Product and Solutions
2.9.4 Numerate AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Numerate Recent Developments and Future Plans
2.10 Cloud Pharmaceuticals
2.10.1 Cloud Pharmaceuticals Details
2.10.2 Cloud Pharmaceuticals Major Business
2.10.3 Cloud Pharmaceuticals AI Drug Development Product and Solutions
2.10.4 Cloud Pharmaceuticals AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Cloud Pharmaceuticals Recent Developments and Future Plans
2.11 IBM
2.11.1 IBM Details
2.11.2 IBM Major Business
2.11.3 IBM AI Drug Development Product and Solutions
2.11.4 IBM AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 IBM Recent Developments and Future Plans
2.12 NuMedii
2.12.1 NuMedii Details
2.12.2 NuMedii Major Business
2.12.3 NuMedii AI Drug Development Product and Solutions
2.12.4 NuMedii AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 NuMedii Recent Developments and Future Plans
2.13 BenevolentAI
2.13.1 BenevolentAI Details
2.13.2 BenevolentAI Major Business
2.13.3 BenevolentAI AI Drug Development Product and Solutions
2.13.4 BenevolentAI AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 BenevolentAI Recent Developments and Future Plans
2.14 Lam Therapeutics
2.14.1 Lam Therapeutics Details
2.14.2 Lam Therapeutics Major Business
2.14.3 Lam Therapeutics AI Drug Development Product and Solutions
2.14.4 Lam Therapeutics AI Drug Development Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Lam Therapeutics Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global AI Drug Development Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of AI Drug Development by Company Revenue
3.2.2 Top 3 AI Drug Development Players Market Share in 2022
3.2.3 Top 6 AI Drug Development Players Market Share in 2022
3.3 AI Drug Development Market: Overall Company Footprint Analysis
3.3.1 AI Drug Development Market: Region Footprint
3.3.2 AI Drug Development Market: Company Product Type Footprint
3.3.3 AI Drug Development Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global AI Drug Development Consumption Value and Market Share by Type (2018-2023)
4.2 Global AI Drug Development Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global AI Drug Development Consumption Value Market Share by Application (2018-2023)
5.2 Global AI Drug Development Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America AI Drug Development Consumption Value by Type (2018-2029)
6.2 North America AI Drug Development Consumption Value by Application (2018-2029)
6.3 North America AI Drug Development Market Size by Country
6.3.1 North America AI Drug Development Consumption Value by Country (2018-2029)
6.3.2 United States AI Drug Development Market Size and Forecast (2018-2029)
6.3.3 Canada AI Drug Development Market Size and Forecast (2018-2029)
6.3.4 Mexico AI Drug Development Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe AI Drug Development Consumption Value by Type (2018-2029)
7.2 Europe AI Drug Development Consumption Value by Application (2018-2029)
7.3 Europe AI Drug Development Market Size by Country
7.3.1 Europe AI Drug Development Consumption Value by Country (2018-2029)
7.3.2 Germany AI Drug Development Market Size and Forecast (2018-2029)
7.3.3 France AI Drug Development Market Size and Forecast (2018-2029)
7.3.4 United Kingdom AI Drug Development Market Size and Forecast (2018-2029)
7.3.5 Russia AI Drug Development Market Size and Forecast (2018-2029)
7.3.6 Italy AI Drug Development Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific AI Drug Development Consumption Value by Type (2018-2029)
8.2 Asia-Pacific AI Drug Development Consumption Value by Application (2018-2029)
8.3 Asia-Pacific AI Drug Development Market Size by Region
8.3.1 Asia-Pacific AI Drug Development Consumption Value by Region (2018-2029)
8.3.2 China AI Drug Development Market Size and Forecast (2018-2029)
8.3.3 Japan AI Drug Development Market Size and Forecast (2018-2029)
8.3.4 South Korea AI Drug Development Market Size and Forecast (2018-2029)
8.3.5 India AI Drug Development Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia AI Drug Development Market Size and Forecast (2018-2029)
8.3.7 Australia AI Drug Development Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America AI Drug Development Consumption Value by Type (2018-2029)
9.2 South America AI Drug Development Consumption Value by Application (2018-2029)
9.3 South America AI Drug Development Market Size by Country
9.3.1 South America AI Drug Development Consumption Value by Country (2018-2029)
9.3.2 Brazil AI Drug Development Market Size and Forecast (2018-2029)
9.3.3 Argentina AI Drug Development Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa AI Drug Development Consumption Value by Type (2018-2029)
10.2 Middle East & Africa AI Drug Development Consumption Value by Application (2018-2029)
10.3 Middle East & Africa AI Drug Development Market Size by Country
10.3.1 Middle East & Africa AI Drug Development Consumption Value by Country (2018-2029)
10.3.2 Turkey AI Drug Development Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia AI Drug Development Market Size and Forecast (2018-2029)
10.3.4 UAE AI Drug Development Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 AI Drug Development Market Drivers
11.2 AI Drug Development Market Restraints
11.3 AI Drug Development Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 AI Drug Development Industry Chain
12.2 AI Drug Development Upstream Analysis
12.3 AI Drug Development Midstream Analysis
12.4 AI Drug Development Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global AI Drug Development Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global AI Drug Development Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global AI Drug Development Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global AI Drug Development Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 6. Insilico Medicine Major Business
Table 7. Insilico Medicine AI Drug Development Product and Solutions
Table 8. Insilico Medicine AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Insilico Medicine Recent Developments and Future Plans
Table 10. Cyclica Company Information, Head Office, and Major Competitors
Table 11. Cyclica Major Business
Table 12. Cyclica AI Drug Development Product and Solutions
Table 13. Cyclica AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Cyclica Recent Developments and Future Plans
Table 15. XtalPi Inc. Company Information, Head Office, and Major Competitors
Table 16. XtalPi Inc. Major Business
Table 17. XtalPi Inc. AI Drug Development Product and Solutions
Table 18. XtalPi Inc. AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. XtalPi Inc. Recent Developments and Future Plans
Table 20. Exscientia Limited Company Information, Head Office, and Major Competitors
Table 21. Exscientia Limited Major Business
Table 22. Exscientia Limited AI Drug Development Product and Solutions
Table 23. Exscientia Limited AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Exscientia Limited Recent Developments and Future Plans
Table 25. AiCure, LLC Company Information, Head Office, and Major Competitors
Table 26. AiCure, LLC Major Business
Table 27. AiCure, LLC AI Drug Development Product and Solutions
Table 28. AiCure, LLC AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. AiCure, LLC Recent Developments and Future Plans
Table 30. Atomwise Company Information, Head Office, and Major Competitors
Table 31. Atomwise Major Business
Table 32. Atomwise AI Drug Development Product and Solutions
Table 33. Atomwise AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Atomwise Recent Developments and Future Plans
Table 35. Biovista Inc. Company Information, Head Office, and Major Competitors
Table 36. Biovista Inc. Major Business
Table 37. Biovista Inc. AI Drug Development Product and Solutions
Table 38. Biovista Inc. AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Biovista Inc. Recent Developments and Future Plans
Table 40. Breg?Inc. Company Information, Head Office, and Major Competitors
Table 41. Breg?Inc. Major Business
Table 42. Breg?Inc. AI Drug Development Product and Solutions
Table 43. Breg?Inc. AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Breg?Inc. Recent Developments and Future Plans
Table 45. Numerate Company Information, Head Office, and Major Competitors
Table 46. Numerate Major Business
Table 47. Numerate AI Drug Development Product and Solutions
Table 48. Numerate AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Numerate Recent Developments and Future Plans
Table 50. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Cloud Pharmaceuticals Major Business
Table 52. Cloud Pharmaceuticals AI Drug Development Product and Solutions
Table 53. Cloud Pharmaceuticals AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 55. IBM Company Information, Head Office, and Major Competitors
Table 56. IBM Major Business
Table 57. IBM AI Drug Development Product and Solutions
Table 58. IBM AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. IBM Recent Developments and Future Plans
Table 60. NuMedii Company Information, Head Office, and Major Competitors
Table 61. NuMedii Major Business
Table 62. NuMedii AI Drug Development Product and Solutions
Table 63. NuMedii AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. NuMedii Recent Developments and Future Plans
Table 65. BenevolentAI Company Information, Head Office, and Major Competitors
Table 66. BenevolentAI Major Business
Table 67. BenevolentAI AI Drug Development Product and Solutions
Table 68. BenevolentAI AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. BenevolentAI Recent Developments and Future Plans
Table 70. Lam Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Lam Therapeutics Major Business
Table 72. Lam Therapeutics AI Drug Development Product and Solutions
Table 73. Lam Therapeutics AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Lam Therapeutics Recent Developments and Future Plans
Table 75. Global AI Drug Development Revenue (USD Million) by Players (2018-2023)
Table 76. Global AI Drug Development Revenue Share by Players (2018-2023)
Table 77. Breakdown of AI Drug Development by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in AI Drug Development, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key AI Drug Development Players
Table 80. AI Drug Development Market: Company Product Type Footprint
Table 81. AI Drug Development Market: Company Product Application Footprint
Table 82. AI Drug Development New Market Entrants and Barriers to Market Entry
Table 83. AI Drug Development Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global AI Drug Development Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global AI Drug Development Consumption Value Share by Type (2018-2023)
Table 86. Global AI Drug Development Consumption Value Forecast by Type (2024-2029)
Table 87. Global AI Drug Development Consumption Value by Application (2018-2023)
Table 88. Global AI Drug Development Consumption Value Forecast by Application (2024-2029)
Table 89. North America AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific AI Drug Development Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific AI Drug Development Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 119. AI Drug Development Raw Material
Table 120. Key Suppliers of AI Drug Development Raw Materials
Table 1. Global AI Drug Development Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global AI Drug Development Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global AI Drug Development Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global AI Drug Development Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Insilico Medicine Company Information, Head Office, and Major Competitors
Table 6. Insilico Medicine Major Business
Table 7. Insilico Medicine AI Drug Development Product and Solutions
Table 8. Insilico Medicine AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Insilico Medicine Recent Developments and Future Plans
Table 10. Cyclica Company Information, Head Office, and Major Competitors
Table 11. Cyclica Major Business
Table 12. Cyclica AI Drug Development Product and Solutions
Table 13. Cyclica AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Cyclica Recent Developments and Future Plans
Table 15. XtalPi Inc. Company Information, Head Office, and Major Competitors
Table 16. XtalPi Inc. Major Business
Table 17. XtalPi Inc. AI Drug Development Product and Solutions
Table 18. XtalPi Inc. AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. XtalPi Inc. Recent Developments and Future Plans
Table 20. Exscientia Limited Company Information, Head Office, and Major Competitors
Table 21. Exscientia Limited Major Business
Table 22. Exscientia Limited AI Drug Development Product and Solutions
Table 23. Exscientia Limited AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Exscientia Limited Recent Developments and Future Plans
Table 25. AiCure, LLC Company Information, Head Office, and Major Competitors
Table 26. AiCure, LLC Major Business
Table 27. AiCure, LLC AI Drug Development Product and Solutions
Table 28. AiCure, LLC AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. AiCure, LLC Recent Developments and Future Plans
Table 30. Atomwise Company Information, Head Office, and Major Competitors
Table 31. Atomwise Major Business
Table 32. Atomwise AI Drug Development Product and Solutions
Table 33. Atomwise AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Atomwise Recent Developments and Future Plans
Table 35. Biovista Inc. Company Information, Head Office, and Major Competitors
Table 36. Biovista Inc. Major Business
Table 37. Biovista Inc. AI Drug Development Product and Solutions
Table 38. Biovista Inc. AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Biovista Inc. Recent Developments and Future Plans
Table 40. Breg?Inc. Company Information, Head Office, and Major Competitors
Table 41. Breg?Inc. Major Business
Table 42. Breg?Inc. AI Drug Development Product and Solutions
Table 43. Breg?Inc. AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Breg?Inc. Recent Developments and Future Plans
Table 45. Numerate Company Information, Head Office, and Major Competitors
Table 46. Numerate Major Business
Table 47. Numerate AI Drug Development Product and Solutions
Table 48. Numerate AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Numerate Recent Developments and Future Plans
Table 50. Cloud Pharmaceuticals Company Information, Head Office, and Major Competitors
Table 51. Cloud Pharmaceuticals Major Business
Table 52. Cloud Pharmaceuticals AI Drug Development Product and Solutions
Table 53. Cloud Pharmaceuticals AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Cloud Pharmaceuticals Recent Developments and Future Plans
Table 55. IBM Company Information, Head Office, and Major Competitors
Table 56. IBM Major Business
Table 57. IBM AI Drug Development Product and Solutions
Table 58. IBM AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. IBM Recent Developments and Future Plans
Table 60. NuMedii Company Information, Head Office, and Major Competitors
Table 61. NuMedii Major Business
Table 62. NuMedii AI Drug Development Product and Solutions
Table 63. NuMedii AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. NuMedii Recent Developments and Future Plans
Table 65. BenevolentAI Company Information, Head Office, and Major Competitors
Table 66. BenevolentAI Major Business
Table 67. BenevolentAI AI Drug Development Product and Solutions
Table 68. BenevolentAI AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. BenevolentAI Recent Developments and Future Plans
Table 70. Lam Therapeutics Company Information, Head Office, and Major Competitors
Table 71. Lam Therapeutics Major Business
Table 72. Lam Therapeutics AI Drug Development Product and Solutions
Table 73. Lam Therapeutics AI Drug Development Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. Lam Therapeutics Recent Developments and Future Plans
Table 75. Global AI Drug Development Revenue (USD Million) by Players (2018-2023)
Table 76. Global AI Drug Development Revenue Share by Players (2018-2023)
Table 77. Breakdown of AI Drug Development by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in AI Drug Development, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key AI Drug Development Players
Table 80. AI Drug Development Market: Company Product Type Footprint
Table 81. AI Drug Development Market: Company Product Application Footprint
Table 82. AI Drug Development New Market Entrants and Barriers to Market Entry
Table 83. AI Drug Development Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global AI Drug Development Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global AI Drug Development Consumption Value Share by Type (2018-2023)
Table 86. Global AI Drug Development Consumption Value Forecast by Type (2024-2029)
Table 87. Global AI Drug Development Consumption Value by Application (2018-2023)
Table 88. Global AI Drug Development Consumption Value Forecast by Application (2024-2029)
Table 89. North America AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific AI Drug Development Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific AI Drug Development Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa AI Drug Development Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa AI Drug Development Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa AI Drug Development Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa AI Drug Development Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa AI Drug Development Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa AI Drug Development Consumption Value by Country (2024-2029) & (USD Million)
Table 119. AI Drug Development Raw Material
Table 120. Key Suppliers of AI Drug Development Raw Materials
LIST OF FIGURES
Figure 1. AI Drug Development Picture
Figure 2. Global AI Drug Development Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global AI Drug Development Consumption Value Market Share by Type in 2022
Figure 4. Drug Design
Figure 5. Drug Synthesis
Figure 6. Other
Figure 7. Global AI Drug Development Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. AI Drug Development Consumption Value Market Share by Application in 2022
Figure 9. Tumor Picture
Figure 10. Nervous System Picture
Figure 11. Other Picture
Figure 12. Global AI Drug Development Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global AI Drug Development Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market AI Drug Development Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global AI Drug Development Consumption Value Market Share by Region (2018-2029)
Figure 16. Global AI Drug Development Consumption Value Market Share by Region in 2022
Figure 17. North America AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 20. South America AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 22. Global AI Drug Development Revenue Share by Players in 2022
Figure 23. AI Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players AI Drug Development Market Share in 2022
Figure 25. Global Top 6 Players AI Drug Development Market Share in 2022
Figure 26. Global AI Drug Development Consumption Value Share by Type (2018-2023)
Figure 27. Global AI Drug Development Market Share Forecast by Type (2024-2029)
Figure 28. Global AI Drug Development Consumption Value Share by Application (2018-2023)
Figure 29. Global AI Drug Development Market Share Forecast by Application (2024-2029)
Figure 30. North America AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 31. North America AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 32. North America AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 33. United States AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 40. France AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific AI Drug Development Consumption Value Market Share by Region (2018-2029)
Figure 47. China AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 50. India AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 53. South America AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 54. South America AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 55. South America AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 64. AI Drug Development Market Drivers
Figure 65. AI Drug Development Market Restraints
Figure 66. AI Drug Development Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of AI Drug Development in 2022
Figure 69. Manufacturing Process Analysis of AI Drug Development
Figure 70. AI Drug Development Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. AI Drug Development Picture
Figure 2. Global AI Drug Development Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global AI Drug Development Consumption Value Market Share by Type in 2022
Figure 4. Drug Design
Figure 5. Drug Synthesis
Figure 6. Other
Figure 7. Global AI Drug Development Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 8. AI Drug Development Consumption Value Market Share by Application in 2022
Figure 9. Tumor Picture
Figure 10. Nervous System Picture
Figure 11. Other Picture
Figure 12. Global AI Drug Development Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 13. Global AI Drug Development Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 14. Global Market AI Drug Development Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 15. Global AI Drug Development Consumption Value Market Share by Region (2018-2029)
Figure 16. Global AI Drug Development Consumption Value Market Share by Region in 2022
Figure 17. North America AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 18. Europe AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 19. Asia-Pacific AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 20. South America AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 21. Middle East and Africa AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 22. Global AI Drug Development Revenue Share by Players in 2022
Figure 23. AI Drug Development Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 24. Global Top 3 Players AI Drug Development Market Share in 2022
Figure 25. Global Top 6 Players AI Drug Development Market Share in 2022
Figure 26. Global AI Drug Development Consumption Value Share by Type (2018-2023)
Figure 27. Global AI Drug Development Market Share Forecast by Type (2024-2029)
Figure 28. Global AI Drug Development Consumption Value Share by Application (2018-2023)
Figure 29. Global AI Drug Development Market Share Forecast by Application (2024-2029)
Figure 30. North America AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 31. North America AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 32. North America AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 33. United States AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 34. Canada AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 35. Mexico AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 36. Europe AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 37. Europe AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 38. Europe AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 39. Germany AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 40. France AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 41. United Kingdom AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 42. Russia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 43. Italy AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 44. Asia-Pacific AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 45. Asia-Pacific AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 46. Asia-Pacific AI Drug Development Consumption Value Market Share by Region (2018-2029)
Figure 47. China AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 48. Japan AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 49. South Korea AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 50. India AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 51. Southeast Asia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 52. Australia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 53. South America AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 54. South America AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 55. South America AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 56. Brazil AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 57. Argentina AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 58. Middle East and Africa AI Drug Development Consumption Value Market Share by Type (2018-2029)
Figure 59. Middle East and Africa AI Drug Development Consumption Value Market Share by Application (2018-2029)
Figure 60. Middle East and Africa AI Drug Development Consumption Value Market Share by Country (2018-2029)
Figure 61. Turkey AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 62. Saudi Arabia AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 63. UAE AI Drug Development Consumption Value (2018-2029) & (USD Million)
Figure 64. AI Drug Development Market Drivers
Figure 65. AI Drug Development Market Restraints
Figure 66. AI Drug Development Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of AI Drug Development in 2022
Figure 69. Manufacturing Process Analysis of AI Drug Development
Figure 70. AI Drug Development Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
